Repaglinide and Lidocaine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Repaglinide (repaglinide) and Lidocaine (lidocaine). Common drug interactions include drug ineffective among females and sinusitis among males.

The phase IV clinical study analyzes what interactions people have when they take Repaglinide and Lidocaine. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.

What is Lidocaine?

Lidocaine has active ingredients of lidocaine. It is often used in pain. eHealthMe is studying from 27,555 Lidocaine users. Check the latest studies of Lidocaine.

On Jul, 10, 2026

20 people who take Repaglinide and Lidocaine together, and have interactions are studied.

Repaglinide and Lidocaine drug interactions.

What are the common drug interactions of Repaglinide and Lidocaine, by gender? *:

female:

Drug ineffective
Nausea (feeling of having an urge to vomit)
Cardiac valve disease (heart valve disease)
Duodenal ulcer
Hypertensive heart disease
Oedema peripheral (superficial swelling)
Osteonecrosis (death of bone)
Renal impairment (severely reduced kidney function)
Spinal fracture (fracture in one of vertebrae)
Thrombosis (formation of a blood clot inside a blood vessel)

male:

Sinusitis (inflammation of sinus)
Cardiac disorder
Anaemia postoperative
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Bacteraemia (presence of bacteria in the blood)
Dementia (madness)
Pneumonia klebsiella (pneumonia caused by bacteria klebsiella)
Respiratory failure (inadequate gas exchange by the respiratory system)
Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
Vision blurred

What are the common drug interactions of Repaglinide and Lidocaine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Arthralgia (joint pain)
Pneumonia
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Bacteraemia (presence of bacteria in the blood)
Blindness
Cardiac valve disease (heart valve disease)
Cellulitis (infection under the skin)
Death
Dementia (madness)
Depression

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 8 people, 40.00%
Immune System Disorder: 3 people, 15.00%
Hypergammaglobulinaemia (elevated levels of gamma globulin): 3 people, 15.00%
Polymyalgia Rheumatica (pain in many muscles): 2 people, 10.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 10.00%
Hypotension (abnormally low blood pressure): 1 person, 5.00%
Breast Cancer: 1 person, 5.00%
Cardiac Disorder: 1 person, 5.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.00%
High Blood Cholesterol: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Repaglinide and Lidocaine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously